Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131 is a research paper published in Cancer (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: UG1 CA189954
NCI NIH HHS
Grant: UG1 CA233340
NCI NIH HHS
Grant: U10 CA180888
NCI NIH HHS
Grant: UG1 CA189856
NCI NIH HHS
Grant: UG1 CA239769
NCI NIH HHS
Grant: UG1 CA189971
NCI NIH HHS
Grant: UG1 CA233320
NCI NIH HHS
Grant: UG1 CA233329
NCI NIH HHS
Grant: U10 CA180794
NCI NIH HHS
Grant: UG1 CA189859
NCI NIH HHS
Grant: U24 CA196172
NCI NIH HHS
Grant: UG1 CA189828
NCI NIH HHS
Grant: UG1 CA189851
NCI NIH HHS
Grant: UG1 CA233196
NCI NIH HHS
Grant: UG1 CA233277
NCI NIH HHS
Grant: UG1 CA233302
NCI NIH HHS
Grant: U10 CA180821
NCI NIH HHS
Grant: U10 CA180868
NCI NIH HHS
Grant: UG1 CA189863
NCI NIH HHS
Grant: UG1 CA189809
NCI NIH HHS
Grant: UG1 CA233270
FWCI
0.54
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords